Immunotherapy of Tumors with Autologous Tumor-Derived Heat Shock Protein Preparations
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Immunotherapy of mice with preexisting cancers with heat shock protein preparations derived from autologous cancer resulted in retarded progression of the primary cancer, a reduced metastatic load, and prolongation of life-span. Treatment with heat shock protein preparations derived from cancers other than the autologous cancer did not provide significant protection. Spontaneous cancers (lung cancer and melanoma), chemically induced cancers (fibrosarcoma and colon carcinoma), and an ultraviolet radiation-induced spindle cell carcinoma were tested, and the results support the efficacy of autologous cancer–derived heat shock protein–peptide complexes in immunotherapy of cancers without the need to identify specific tumor antigenic epitopes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
Self-citationHeat shock protein 70-associated peptides elicit specific cancer immunity.
Udono, H., & Srivastava, P. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1391 · Cited by 621
Self-citationHeat shock proteins transfer peptides during antigen processing and CTL priming
Srivastava, P., Udono, H., Blachere, N., & Li, Z. (1994) · Immunogenetics · doi:10.1007/bf00188611 · Cited by 569
Self-citationTumor rejection antigens of chemically induced sarcomas of inbred mice.
Srivastava, P. K., DeLeo, A. B., & Old, L. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3407 · Cited by 457
Self-citationHuang, A. Y., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., Engelhard, V. H., Pasternack, G., Cotter, R., Hunt, D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9730 · Cited by 388
Udono, H., Levey, D. L., & Srivastava, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3077 · Cited by 347
Self-citationArnold, D., Faath, S., Rammensee, H., & Schild, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.885 · Cited by 330
Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., & Ohashi, P. S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.645 · Cited by 309
Li, Z., & Srivastava, P. K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05983.x · Cited by 285
Self-citation
Cited by
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
The cellular and molecular basis of hyperthermia
Hildebrandt, B. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00179-2 · Cited by 1,718
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Asea, A., Kraeft, S.-K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., & Calderwood, S. K. (2000) · Nature Medicine · doi:10.1038/74697 · Cited by 1,620
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Roles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069
Self-citationRole of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell Death
Jolly, C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1564 · Cited by 1,048
The 90-kDa Molecular Chaperone Family
Csermely, P., Schnaider, T., So″ti, C., Prohászka, Z., & Nardai, G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00013-8 · Cited by 1,028
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
More than one reason to rethink the use of peptides in vaccine design
Purcell, A. W., McCluskey, J., & Rossjohn, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2224 · Cited by 860
Srivastava, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064801 · Cited by 850
Self-citationA fresh look at tumor immunosurveillance and immunotherapy
Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001) · Nature Immunology · doi:10.1038/86297 · Cited by 745
CD91: a receptor for heat shock protein gp96
Binder, R. J., Han, D. K., & Srivastava, P. K. (2000) · Nature Immunology · doi:10.1038/77835 · Cited by 671
Self-citation(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00007-1 · Cited by 594
Role of Heat Shock Proteins in Protection from and Pathogenesis of Infectious Diseases
Zügel, U., & Kaufmann, S. H. E. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.19 · Cited by 559
Heat Shock Proteins Come of Age: Primitive Functions Acquire New Roles in an Adaptive World
Srivastava, P. K., Menoret, A., Basu, S., Binder, R. J., & McQuade, K. L. (1998) · Immunity · doi:10.1016/s1074-7613(00)80570-1 · Cited by 540
Self-citationInvolvement of LOX-1 in Dendritic Cell-Mediated Antigen Cross-Presentation
Delneste, Y., Magistrelli, G., Gauchat, J.-F., Haeuw, J.-F., Aubry, J.-P., Nakamura, K., Kawakami-Honda, N., Goetsch, L., Sawamura, T., Bonnefoy, J.-Y., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00388-6 · Cited by 529
Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., & Vile, R. G. (1998) · Nature Medicine · doi:10.1038/nm0598-581 · Cited by 445
Pardoll, D. M. (1998) · Nature Medicine · doi:10.1038/nm0598supp-525 · Cited by 428
Yang, D., Han, Z., & Oppenheim, J. J. (2017) · Immunological Reviews · doi:10.1111/imr.12577 · Cited by 405
Belli, F., Testori, A., Rivoltini, L., Maio, M., Andreola, G., Sertoli, M. R., Gallino, G., Piris, A., Cattelan, A., Lazzari, I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.134 · Cited by 387
Self-citationThe HSP90 family of genes in the human genome: Insights into their divergence and evolution
Chen, B., Piel, W. H., Gui, L., Bruford, E., & Monteiro, A. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.012 · Cited by 383
The Makings of a Tumor Rejection Antigen
Gilboa, E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80101-6 · Cited by 381
Spinning molecular immunology into successful immunotherapy
Pardoll, D. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri774 · Cited by 360
Fingerprinting the circulating repertoire of antibodies from cancer patients
Mintz, P. J., Kim, J., Do, K.-A., Wang, X., Zinner, R. G., Cristofanilli, M., Arap, M. A., Hong, W. K., Troncoso, P., Logothetis, C. J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt774 · Cited by 345
Functional magnetic particles for medical application
Shinkai, M. (2002) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(02)80202-x · Cited by 343
Wood, C., Srivastava, P., Bukowski, R., Lacombe, L., Gorelov, A. I., Gorelov, S., Mulders, P., Zielinski, H., Hoos, A., Teofilovici, F., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60697-2 · Cited by 332
Self-citationFunctional Magnetic Particles for Medical Application.
SHINKAI, M. (2002) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.94.606 · Cited by 331
Todryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P., Stoppacciaro, A., & Vile, R. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1398 · Cited by 328
Cancer immunotherapy with mRNA‐transfected dendritic cells
Gilboa, E., & Vieweg, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00139.x · Cited by 316
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Hamdy, S., Haddadi, A., Hung, R. W., & Lavasanifar, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.021 · Cited by 298
Current Developments in Cancer Vaccines and Cellular Immunotherapy
Ribas, A., Butterfield, L. H., Glaspy, J. A., & Economou, J. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.041 · Cited by 295
Pockley, A. G., Shepherd, J., & Corton, J. M. (1998) · Immunological Investigations · doi:10.3109/08820139809022710 · Cited by 289
Yewdell, J. W., Norbury, C. C., & Bennink, J. R. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60785-3 · Cited by 284
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
GRP78: A Multifunctional Receptor on the Cell Surface
Gonzalez–Gronow, M., Selim, M. A., Papalas, J., & Pizzo, S. V. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2568 · Cited by 266
Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells
Noessner, E., Gastpar, R., Milani, V., Brandl, A., Hutzler, P. J. S., Kuppner, M. C., Roos, M., Kremmer, E., Asea, A., Calderwood, S. K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5424 · Cited by 262
Heat Shock Proteins gp96 and hsp70 Activate the Release of Nitric Oxide by APCs
Panjwani, N. N., Popova, L., & Srivastava, P. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2997 · Cited by 259
Self-citationTestori, A., Richards, J., Whitman, E., Mann, G. B., Lutzky, J., Camacho, L., Parmiani, G., Tosti, G., Kirkwood, J. M., Hoos, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9941 · Cited by 257
Self-citationRao, Q., Zuo, B., Lu, Z., Gao, X., You, A., Wu, C., Du, Z., & Yin, H. (2016) · Hepatology · doi:10.1002/hep.28549 · Cited by 246
Nemunaitis, J., Sterman, D., Jablons, D., Smith, J. W., Fox, B., Maples, P., Hamilton, S., Borellini, F., Lin, A., Morali, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh028 · Cited by 244
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., & Hämmerling, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5247 · Cited by 220
Cutting Edge: Heat Shock Protein gp96 Induces Maturation and Migration of CD11c+ Cells In Vivo
Binder, R. J., Anderson, K. M., Basu, S., & Srivastava, P. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6029 · Cited by 216
“Mature CD11c 1 cells migrate to the LNs (4), where they stimulate naive T cells (5).”
BackgroundSelf-citationActivation of natural killer cells by heat shock protein 70
Multhoff, G. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902902001 · Cited by 182
Functions of Heat Shock Proteins in Pathways of the Innate and Adaptive Immune System
Binder, R. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401417 · Cited by 175
Ito, A., Shinkai, M., Honda, H., Yoshikawa, K., Saga, S., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0335-x · Cited by 174
“been demonstrated that tumor-derived HSP-peptide complexes can elicit cancer immunity [21, 33, 34].”
BackgroundChu, N. R., Wu, H. B., Wu, T.-C., Boux, L. J., Siegel, M. I., & Mizzen, L. A. (2008) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01293.x · Cited by 172
TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings
Shetab Boushehri, M. A., & Lamprecht, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00691 · Cited by 161
Chen, X. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.123 · Cited by 81
“Immunization with Grp94– peptide complexes derived from cancer cells elicits a potent T cell response against the cancer cells from which the Grp94– peptide complexes were purified ( 35 ).”
Metadata
- Authors
- Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K.
- Venue
- Science
- Published
- 1997-10-03
- Volume
- 278
- Issue
- 5335
- Pages
- 117-120
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2080335579
- Cited by
- 680
- References
- 25
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.